Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D.

Neurology. 2014 Apr 29;82(17):1556-63. doi: 10.1212/WNL.0000000000000363. Review.

PMID:
24778283
[PubMed - indexed for MEDLINE]
2.

Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.

Yadav V, Bever C Jr, Bowen J, Bowling A, Weinstock-Guttman B, Cameron M, Bourdette D, Gronseth GS, Narayanaswami P.

Neurology. 2014 Mar 25;82(12):1083-92. doi: 10.1212/WNL.0000000000000250.

PMID:
24663230
[PubMed - indexed for MEDLINE]
3.

Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary.

Yadav V, Narayanaswami P.

Clin Ther. 2014 Dec 1;36(12):1972-8. doi: 10.1016/j.clinthera.2014.10.011. Epub 2014 Nov 15.

PMID:
25467189
[PubMed - in process]
4.

Pharmacology: Cannabis in neurology--a potted review.

Hosking R, Zajicek J.

Nat Rev Neurol. 2014 Aug;10(8):429-30. doi: 10.1038/nrneurol.2014.122. Epub 2014 Jul 8. No abstract available.

PMID:
25002109
[PubMed - indexed for MEDLINE]
5.

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT.

Neurology. 2012 Mar 27;78(13):1009-15. doi: 10.1212/WNL.0b013e31824de293. Review.

PMID:
22454268
[PubMed - indexed for MEDLINE]
6.

Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.

[No authors listed]

Drugs R D. 2003;4(5):306-9. Review.

PMID:
12952500
[PubMed - indexed for MEDLINE]
7.

Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.

Moreno Torres I, Sanchez AJ, Garcia-Merino A.

Expert Rev Neurother. 2014 Nov;14(11):1243-50. doi: 10.1586/14737175.2014.971758.

PMID:
25331416
[PubMed - in process]
8.

Treatment of Tourette syndrome with cannabinoids.

Müller-Vahl KR.

Behav Neurol. 2013;27(1):119-24. doi: 10.3233/BEN-120276. Review.

PMID:
23187140
[PubMed - indexed for MEDLINE]
9.

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation.

PM R. 2011 Apr;3(4):345-52, 352.e1-21. doi: 10.1016/j.pmrj.2011.03.008. Review.

PMID:
21497321
[PubMed - indexed for MEDLINE]
10.

Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.

Podda G, Constantinescu CS.

Expert Opin Biol Ther. 2012 Nov;12(11):1517-31. doi: 10.1517/14712598.2012.721765. Epub 2012 Sep 7.

PMID:
22954177
[PubMed - in process]
11.

Recent developments in the therapeutic potential of cannabinoids.

Corey S.

P R Health Sci J. 2005 Mar;24(1):19-26. Review.

PMID:
15895873
[PubMed - indexed for MEDLINE]
12.
13.

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.

Zesiewicz TA, Elble RJ, Louis ED, Gronseth GS, Ondo WG, Dewey RB Jr, Okun MS, Sullivan KL, Weiner WJ.

Neurology. 2011 Nov 8;77(19):1752-5. doi: 10.1212/WNL.0b013e318236f0fd. Epub 2011 Oct 19. Review.

PMID:
22013182
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A.

Neurology. 2011 Jan 18;76(3):294-300. doi: 10.1212/WNL.0b013e318207b1f6. Review.

PMID:
21242498
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Bhidayasiri R, Fahn S, Weiner WJ, Gronseth GS, Sullivan KL, Zesiewicz TA; American Academy of Neurology.

Neurology. 2013 Jul 30;81(5):463-9. doi: 10.1212/WNL.0b013e31829d86b6. Review. Erratum in: Neurology. 2013 Nov 26;81(22):1968.

PMID:
23897874
[PubMed - indexed for MEDLINE]
16.

Medical marijuana in neurology.

Benbadis SR, Sanchez-Ramos J, Bozorg A, Giarratano M, Kalidas K, Katzin L, Robertson D, Vu T, Smith A, Zesiewicz T.

Expert Rev Neurother. 2014 Dec;14(12):1453-65. doi: 10.1586/14737175.2014.985209.

PMID:
25427150
[PubMed - in process]
17.

Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.

Muayqil T, Gronseth G, Camicioli R.

Neurology. 2012 Oct 2;79(14):1499-506. doi: 10.1212/WNL.0b013e31826d5fc3. Epub 2012 Sep 19.

PMID:
22993290
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT Jr; American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association-Convened Physician Consortium for Performance Improvement Independent Measure Development Process.

Neurology. 2011 Jan 4;76(1):94-9. doi: 10.1212/WNL.0b013e318203e9d1.

PMID:
21205698
[PubMed - indexed for MEDLINE]
19.
20.

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.

Allsop DJ, Copeland J, Lintzeris N, Dunlop AJ, Montebello M, Sadler C, Rivas GR, Holland RM, Muhleisen P, Norberg MM, Booth J, McGregor IS.

JAMA Psychiatry. 2014 Mar;71(3):281-91. doi: 10.1001/jamapsychiatry.2013.3947.

PMID:
24430917
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk